VIVUS Awarded Two US Patents for Qsymia; Patent Coverage for Qsymia Extended to 2029

VIVUS (NASDAQ: VVUS ) today announced that the United States Patent and Trademark Office has issued U.S. Patent Nos. 8,580,298 (link: 8580298; '298), covering compositions of Qsymia, and 8,580,299 (link: 8580299; '299), covering methods for effecting weight loss using Qsymia. The newly issued patents are assigned to VIVUS and are